ASTRAZENECA PLC 13D/13G Filings for Monopar Therapeutics Inc. (MNPR)

ASTRAZENECA PLC 13D and 13G filings for Monopar Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-10-28
06:00 am
Purchase
2024-10-23 13G Monopar Therapeutics Inc.
MNPR
ASTRAZENECA PLC 387,329
9.900%
387,329increase
(New Position)
Filing